Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02543762
Other study ID # 3-Ceron
Secondary ID
Status Completed
Phase N/A
First received May 20, 2014
Last updated September 4, 2015
Start date February 2012
Est. completion date May 2015

Study information

Verified date September 2015
Source Hospital Clinic of Barcelona
Contact n/a
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Observational [Patient Registry]

Clinical Trial Summary

To assess the feasibility and effectiveness of a program in L-IBD patients using CE targeted biopsies


Description:

We aim to know the prevalence and incidence of dysplasia and colitis-associated colorectal cancer in patients with longstanding colonic inflammatory bowel disease (N-IBD), in Spain and the usefulness of advanced endoscopy (chromoendoscopy) for the diagnosis and endoscopic differential diagnosis of N-IBD.


Recruitment information / eligibility

Status Completed
Enrollment 350
Est. completion date May 2015
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of UC or colitis EC corroborated by clinical and histology

- involvement of at least one third of the colon in patients with CD

- involvement proximal to the rectum in patients with UC

- Duration of disease > 10 years

- No clinical activity:

- May Score <6

- CDEIS <3.5

Exclusion Criteria:

- Personal history of CRC

- colectomy

- coagulopathy

- refusal to participate in the study

- known allergy to indigo carmine

- colonoscopy in the last 6 months

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Procedure:
Chromoendoscopy
Chromoendoscopy involves the topical application of stains to improve tissue localization and characterization of lessions during endoscopy . Chromoendoscopy has been used in patients undergoing colonoscopy, including those undergoing surveillance for chronic ulcerative colitis. Using pit pattern classifications, chromoendoscopy has a high sensitivity and specificity for differentiating neoplastic from non-neoplastic lesions

Locations

Country Name City State
Spain Gastroenteroly Department, Hospital Clinic Barcelona
Spain Hospital de Sant Pau Barcelona
Spain Hospital del Mar Barcelona
Spain Hospital Sant Jaume de Calella Calella Barcelona
Spain Hospital Universitario de Bellvitge Hospitalet de Llobregat Barcelona
Spain Hospital 12 de Octubre Madrid
Spain Hospital Puerta del Hierro Madrid
Spain Hospital Ramón y Cajal Madrid
Spain Hospital General de Manresa Manresa Barcelona
Spain Hospital general de Mostoles Mostoles Madrid
Spain Complexo Hospitalario Universitario de Ourense Ourense Pontevedra
Spain Hospital Universitario de Canarias Tenerife
Spain Hospital de la Fe Valencia
Spain Hospital Peset Valencia
Spain Complexo Hospitalario Universitario de Vigo Vigo Pontevedra

Sponsors (15)

Lead Sponsor Collaborator
Hospital Clinic of Barcelona Complexo Hospitalario de Ourense, Complexo Hospitalario Universitario de Vigo, Hospital de Calella, Hospital de Manresa, Hospital de Sant Pau, Hospital del Mar, Hospital General de Mostoles, Hospital Universitari de Bellvitge, Hospital Universitario 12 de Octubre, Hospital Universitario de Canarias, Hospital Universitario Doctor Peset, Hospital Universitario La Fe, Hospital Universitario Ramon y Cajal, Puerta de Hierro University Hospital

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence and incidence of dysplasia and colitis-associated colorectal cancer in patients with longstanding colonic inflammatory bowel disease (N-IBD), in Spain see title two year No
Secondary Usefulness of advanced endoscopy in displasia characterization (chromoendoscopy ) for the diagnosis and endoscopic differential diagnosis of NIBD. see title two year No
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A